Report
DOWNLOAD REPORT
The 2024 Milken Institute Future of Health Summit centered on the theme Partnering for Better Health. The two-day event featured more than 200 speakers across diverse industries and sectors in more than 50 sessions about innovative partnerships, targeted research, best practices, and policy priorities emerging from biomedical innovation, public health, food, healthy aging, and strategic philanthropy.
This brief summarizes the key trends, ideas, and solutions discussed at the Milken Institute Future of Health Summit.
Related Content
-
Ann Theodore Foundation Breakthrough Sarcoidosis Initiative Grant Awardees 2023
The Ann Theodore Foundation and the Milken Institute are pleased to announce the five research teams selected to receive funding for research to advance understanding of the underlying biology of sarcoidosis, a poorly understood immune...Read Article -
Consensus Definition of Misophonia A Delphi Study
Misophonia was named and described in the early 2000’s (Jastreboff and Jastreboff, 2001, 2002) and has since gained scientific recognition and clinical identification across a wide variety of disciplines (e.g., audiology, neuroscience...Read Report -
Baszucki Brain Research Fund and Milken Institute Announce Grant Recipients for Bipolar Disorder Therapeutic Research
Washington, D.C. – January 13, 2022 – The Baszucki Brain Research Fund and the Milken Institute’s Center for Strategic Philanthropy are pleased to announce that 45 scientists worldwide will receive funding to advance research for bipolar...Read ArticleImageChad Clinton
Director, Media RelationsChad Clinton is the director of media relations for the Milken Institute. Hired to this role in August 2021, Clinton develops and executes strategies to amplify the Institute’s core messages by generating coverage of its pillar workstreams, experts, and events. -
An Overview of Pediatric Preventive Health Care in the United States
Healthy children are the cornerstone of a healthy world. This is why ensuring that children thrive has been the focus of many philanthropic efforts over the centuries. US-based donors who enter the space often do so because of a distressing...Read Report -
Milken Institute Future of Health Summit Opens Tomorrow, December 7
Albert Bourla, Anthony Fauci, Margaret Hamburg among 175+ speakers Washington, DC – Dec. 6, 2020 – The Milken Institute Future of Health Summit kicks off tomorrow, drawing more than 1,000 leaders from government, science, education...Read Article -
Chronic Myelomonocytic Leukemia - A Giving Smarter Guide
Poor treatment options. No Cure. Patients and families affected by chronic myelomonocytic leukemia (CMML) face many challenges and critical unmet needs, issues mirrored by the current state of the disease’s research. On a societal scale...Read Report -
Expanding the Science of Patient Input: Pain Points and Potential
Patient engagement has been called the “blockbuster drug of the 21 st century.” Studies find that the more engaged and involved patients are with their health and health care, the better the outcomes. There is now growing interest in...Read Report -
Amyotrophic Lateral Sclerosis (ALS) A Giving Smarter Guide
ALS, commonly known as Lou Gehrig’s disease or motor neurone disease (MND), is a cruel disease that has challenged patients, their families, and the medical community for generations. Although ALS is considered rare, its impact on...Read Report11
-
Advancing Scientific Sarcoidosis Research
Sarcoidosis is a complex, difficult-to-diagnose condition that can present in a variety of ways. It can disappear without symptoms in a couple of years for some people or lead to organ damage and death in others. Current treatment options...Read Article -
Type 1 Diabetes Autoantibody Screening: A Roadmap for Pediatric Policy Implementation
Type 1 diabetes, or T1D, once commonly known as juvenile diabetes, is an autoimmune disease in which the immune system attacks the insulin-producing cells of the pancreas. The disease affects people of all ages and causes numerous negative...Read Report -
Milken Institute and Baszucki Brain Research Fund Launch New Funding Program for Bipolar Disorder Research
Multimillion-dollar program dedicates funds to advance understanding of bipolar disorder treatment options; Initial letters of intent due May 14, 2021. Washington, DC – April 12, 2021 – The Milken Institute’s Center for Strategic...Read Article -
Glioblastoma Multiforme: A Giving Smarter Guide to Accelerating Research Progress
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the brain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe. The prognosis for...Read Report